At every step of the research process from the lab to the clinic, we are pursuing innovative ways to prevent and control cancer.
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses artificial intelligence algorithms to use its output to design personalized cancer vaccines for patients.
The latest Ludwig Link features an excerpt on Daniel Ludwig from our recently published A Vision Realized: The History of Ludwig Cancer Research and news on major changes to Ludwig’s leadership.
Three early-career researchers—two in grad school, one all set to start his own lab—put down their pipettes to chat with us about themselves, their research and various other matters.
